Neurogene Inc. Company Information

Neurogene Inc.'s employee growth, exchange listings and data sources

Key Information

Name: Neurogene Inc.
Ticker: UU8
Exchange: DB
Founded: NaN
Industry: Biotechnology
Sector: Pharmaceuticals & Biotech
Market Cap: US$382.578m
Listing Market Cap: US$362.110m
Shares Outstanding: 14.83m
Website: https://www.neurogene.com

Number of Employees

Location

Neurogene Inc.
535 W 24th Street
5th Floor
New York
New York
10011
United States

Listings

Ticker	Exchange	Primary Security	Security Type	Country	Currency	Listed on
NGNE	NasdaqGM (Nasdaq Global Market)	Yes	Common Stock	US	USD	Dec 2023
UU8	BST (Boerse-Stuttgart)	Yes	Common Stock	DE	EUR	Dec 2023
UU8	DB (Deutsche Boerse AG)	Yes	Common Stock	DE	EUR	Dec 2023

Company Analysis and Financial Data Status

All financial data provided by Standard & Poor's Capital IQ.
Data	Last Updated (UTC time)
Company Analysis	2024/11/28 12:18
End of Day Share Price	2024/11/22 00:00
Earnings	2024/09/30
Annual Earnings	2023/12/31

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.